Answer
Mecasermin activates the Type 1 insulin-like growth factor-1 (IGF-1) receptor in target tissues, triggering intracellular signalling that stimulates statural growth.
Sources for this answer
- Increlex 10 mg/ml solution for injectionEsteve Pharmaceuticals (formerly Intrapharm Laboratories) · emc · SmPC §5.1 Pharmacodynamic properties · Version 2Document updated
Sources checked